NRG4 and metabolic syndrome: Neuregulin 4 is decreased in obese individuals with metabolic syndrome (MUO-like phenotype) and negatively correlated with waist circumference, body AT percentage, BMI, LDL cholesterol, and fasting glucose concentration.